Selected research
Industry Growth & Trends
Global Vitamin B12 Series API Industry Growth and Trends Forecast to 2032
Market perspective
The global Vitamin B12 Series API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Vitamin B12 Series API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Vitamin B12 Series API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vitamin B12 Series API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vitamin B12 Series API include EUROAPI, Eisai Co., Ltd, HTBA, North China Pharmaceutical Company, Ningxia Kingvit Pharmaceutical, Cspc Holdings Company and Yufeng Industry Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Vitamin B12 Series API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vitamin B12 Series API market size, estimates, and forecasts are presented in terms of sales volume (K G) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vitamin B12 Series API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vitamin B12 Series API.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Vitamin B12 Series API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vitamin B12 Series API Market by Company
EUROAPI
Eisai Co., Ltd
HTBA
North China Pharmaceutical Company
Ningxia Kingvit Pharmaceutical
Cspc Holdings Company
Yufeng Industry Group
Vitamin B12 Series API Segment by Type
Adenosylcobalamin
Cyanocobalamin
Hydroxocobalamin
Methylcobalamin
Vitamin B12 Series API Segment by Application
Oral Formulation
Sprays
Injectable Formulation
Vitamin B12 Series API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin B12 Series API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin B12 Series API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin B12 Series API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vitamin B12 Series API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vitamin B12 Series API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adenosylcobalamin
- Cyanocobalamin
- Hydroxocobalamin
- Methylcobalamin
Applications
- Oral Formulation
- Sprays
- Injectable Formulation
Companies covered
- EUROAPI
- Eisai Co., Ltd
- HTBA
- North China Pharmaceutical Company
- Ningxia Kingvit Pharmaceutical
- Cspc Holdings Company
- Yufeng Industry Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Vitamin B12 Series API Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Vitamin B12 Series API Sales Estimates and Forecasts (2021-2032)
- 1.3 Vitamin B12 Series API Market by Type
- 1.3.1 Adenosylcobalamin
- 1.3.2 Cyanocobalamin
- 1.3.3 Hydroxocobalamin
- 1.3.4 Methylcobalamin
- 1.4 Global Vitamin B12 Series API Market Size by Type
- 1.4.1 Global Vitamin B12 Series API Market Size Overview by Type (2021-2032)
- 1.4.2 Global Vitamin B12 Series API Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Vitamin B12 Series API Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Vitamin B12 Series API Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Vitamin B12 Series API Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Vitamin B12 Series API Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Vitamin B12 Series API Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Vitamin B12 Series API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Vitamin B12 Series API Industry Trends
- 2.2 Vitamin B12 Series API Industry Drivers
- 2.3 Vitamin B12 Series API Industry Opportunities and Challenges
- 2.4 Vitamin B12 Series API Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Vitamin B12 Series API Revenue (2021-2026)
- 3.2 Global Top Players by Vitamin B12 Series API Sales (2021-2026)
- 3.3 Global Top Players by Vitamin B12 Series API Price (2021-2026)
- 3.4 Global Vitamin B12 Series API Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vitamin B12 Series API Major Company Production Sites & Headquarters
- 3.6 Global Vitamin B12 Series API Company, Product Type & Application
- 3.7 Global Vitamin B12 Series API Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vitamin B12 Series API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vitamin B12 Series API Players Market Share by Revenue in 2025
- 3.8.3 2025 Vitamin B12 Series API Tier 1, Tier 2, and Tier 3
4 Vitamin B12 Series API Regional Status and Outlook
- 4.1 Global Vitamin B12 Series API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Vitamin B12 Series API Historic Market Size by Region
- 4.2.1 Global Vitamin B12 Series API Sales in Volume by Region (2021-2026)
- 4.2.2 Global Vitamin B12 Series API Sales in Value by Region (2021-2026)
- 4.2.3 Global Vitamin B12 Series API Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Vitamin B12 Series API Forecasted Market Size by Region
- 4.3.1 Global Vitamin B12 Series API Sales in Volume by Region (2027-2032)
- 4.3.2 Global Vitamin B12 Series API Sales in Value by Region (2027-2032)
- 4.3.3 Global Vitamin B12 Series API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vitamin B12 Series API by Application
- 5.1 Vitamin B12 Series API Market by Application
- 5.1.1 Oral Formulation
- 5.1.2 Sprays
- 5.1.3 Injectable Formulation
- 5.2 Global Vitamin B12 Series API Market Size by Application
- 5.2.1 Global Vitamin B12 Series API Market Size Overview by Application (2021-2032)
- 5.2.2 Global Vitamin B12 Series API Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Vitamin B12 Series API Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Vitamin B12 Series API Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Vitamin B12 Series API Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Vitamin B12 Series API Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Vitamin B12 Series API Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Vitamin B12 Series API Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 EUROAPI
- 6.1.1 EUROAPI Company Information
- 6.1.2 EUROAPI Business Overview
- 6.1.3 EUROAPI Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 EUROAPI Vitamin B12 Series API Product Portfolio
- 6.1.5 EUROAPI Recent Developments
- 6.2 Eisai Co., Ltd
- 6.2.1 Eisai Co., Ltd Company Information
- 6.2.2 Eisai Co., Ltd Business Overview
- 6.2.3 Eisai Co., Ltd Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Eisai Co., Ltd Vitamin B12 Series API Product Portfolio
- 6.2.5 Eisai Co., Ltd Recent Developments
- 6.3 HTBA
- 6.3.1 HTBA Company Information
- 6.3.2 HTBA Business Overview
- 6.3.3 HTBA Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 HTBA Vitamin B12 Series API Product Portfolio
- 6.3.5 HTBA Recent Developments
- 6.4 North China Pharmaceutical Company
- 6.4.1 North China Pharmaceutical Company Company Information
- 6.4.2 North China Pharmaceutical Company Business Overview
- 6.4.3 North China Pharmaceutical Company Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 North China Pharmaceutical Company Vitamin B12 Series API Product Portfolio
- 6.4.5 North China Pharmaceutical Company Recent Developments
- 6.5 Ningxia Kingvit Pharmaceutical
- 6.5.1 Ningxia Kingvit Pharmaceutical Company Information
- 6.5.2 Ningxia Kingvit Pharmaceutical Business Overview
- 6.5.3 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Product Portfolio
- 6.5.5 Ningxia Kingvit Pharmaceutical Recent Developments
- 6.6 Cspc Holdings Company
- 6.6.1 Cspc Holdings Company Company Information
- 6.6.2 Cspc Holdings Company Business Overview
- 6.6.3 Cspc Holdings Company Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Cspc Holdings Company Vitamin B12 Series API Product Portfolio
- 6.6.5 Cspc Holdings Company Recent Developments
- 6.7 Yufeng Industry Group
- 6.7.1 Yufeng Industry Group Company Information
- 6.7.2 Yufeng Industry Group Business Overview
- 6.7.3 Yufeng Industry Group Vitamin B12 Series API Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Yufeng Industry Group Vitamin B12 Series API Product Portfolio
- 6.7.5 Yufeng Industry Group Recent Developments
7 North America by Country
- 7.1 North America Vitamin B12 Series API Sales by Country
- 7.1.1 North America Vitamin B12 Series API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Vitamin B12 Series API Sales by Country (2021-2026)
- 7.1.3 North America Vitamin B12 Series API Sales Forecast by Country (2027-2032)
- 7.2 North America Vitamin B12 Series API Market Size by Country
- 7.2.1 North America Vitamin B12 Series API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Vitamin B12 Series API Market Size by Country (2021-2026)
- 7.2.3 North America Vitamin B12 Series API Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Vitamin B12 Series API Sales by Country
- 8.1.1 Europe Vitamin B12 Series API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Vitamin B12 Series API Sales by Country (2021-2026)
- 8.1.3 Europe Vitamin B12 Series API Sales Forecast by Country (2027-2032)
- 8.2 Europe Vitamin B12 Series API Market Size by Country
- 8.2.1 Europe Vitamin B12 Series API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Vitamin B12 Series API Market Size by Country (2021-2026)
- 8.2.3 Europe Vitamin B12 Series API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Vitamin B12 Series API Sales by Country
- 9.1.1 Asia-Pacific Vitamin B12 Series API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Vitamin B12 Series API Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Vitamin B12 Series API Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Vitamin B12 Series API Market Size by Country
- 9.2.1 Asia-Pacific Vitamin B12 Series API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Vitamin B12 Series API Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Vitamin B12 Series API Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Vitamin B12 Series API Sales by Country
- 10.1.1 South America Vitamin B12 Series API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Vitamin B12 Series API Sales by Country (2021-2026)
- 10.1.3 South America Vitamin B12 Series API Sales Forecast by Country (2027-2032)
- 10.2 South America Vitamin B12 Series API Market Size by Country
- 10.2.1 South America Vitamin B12 Series API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Vitamin B12 Series API Market Size by Country (2021-2026)
- 10.2.3 South America Vitamin B12 Series API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Vitamin B12 Series API Sales by Country
- 11.1.1 Middle East and Africa Vitamin B12 Series API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Vitamin B12 Series API Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Vitamin B12 Series API Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Vitamin B12 Series API Market Size by Country
- 11.2.1 Middle East and Africa Vitamin B12 Series API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Vitamin B12 Series API Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Vitamin B12 Series API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Vitamin B12 Series API Value Chain Analysis
- 12.1.1 Vitamin B12 Series API Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Vitamin B12 Series API Production Mode & Process
- 12.2 Vitamin B12 Series API Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Vitamin B12 Series API Distributors
- 12.2.3 Vitamin B12 Series API Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst